@article{02b7dfe63f5c4253a714a6281ffce9af,
title = "Correction to: N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial (Annals of Oncology (2010) 21(8) (1729–1730), (S0923753419353116), (10.1093/annonc/mdp328))",
abstract = "Ann Oncol 2010; 21: 493–497 (doi: 10.1093/annonc/mdp328) The following funding statement was missing from the original manuscript: {\textquoteleft}Supported by NIH grant U10CA025224 to the North Central Cancer Treatment Program.{\textquoteright} This has now been amended in the online version.",
author = "Tan, {W. W.} and Hillman, {D. W.} and M. Salim and Northfelt, {D. W.} and Anderson, {D. M.} and Stella, {P. J.} and R. Niedringhaus and Bernath, {A. M.} and Gamini, {S. S.} and F. Palmieri and Perez, {E. A.}",
note = "Publisher Copyright: {\textcopyright} 2018 THE AUTHORS",
year = "2018",
month = oct,
doi = "10.1093/annonc/mdx811",
language = "English (US)",
volume = "29",
pages = "2150",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "10",
}